[Federal Register Volume 87, Number 128 (Wednesday, July 6, 2022)]
[Notices]
[Pages 40280-40281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-14287]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2017-0091]


Regulatory Analysis Guidelines

AGENCY: Nuclear Regulatory Commission.

ACTION: Draft NUREG appendices; request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for 
public comment two draft appendices to NUREG/BR-0058, Revision 5, 
``Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory 
Commission.'' Guidance in these draft appendices provides information 
that the staff will use when performing cost-benefit analyses in 
support of regulatory decisions. Section II of this document describes 
each draft appendix.

DATES: Submit comments by September 6, 2022. Comments received after 
this date will be considered if it is practical to do so, but the NRC 
can only ensure the consideration of comments received before this 
date.

ADDRESSES: You may submit comments by any of the following methods; 
however, the NRC encourages electronic comment submission through the 
Federal rulemaking website:
    <bullet> Federal rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2017-0091. Address 
questions about Docket IDs in Regulations.gov to Stacy Schumann; 
telephone: 301-415-0624; email: <a href="/cdn-cgi/l/email-protection#c596b1a4a6bceb96a6adb0a8a4abab85abb7a6eba2aab3"><span class="__cf_email__" data-cfemail="481b3c292b31661b2b203d2529262608263a2b662f273e">[email protected]</span></a>. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
    <bullet> Mail comments to: Office of Administration, Mail Stop: 
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555 -
0001, ATTN: Program Management, Announcements and Editing Staff.
    For additional directions on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Pamela Noto, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555 -0001; telephone: 301-415-6795; email: 
<a href="/cdn-cgi/l/email-protection#c797a6aaa2aba6e989a8b3a887a9b5a4e9a0a8b1"><span class="__cf_email__" data-cfemail="e4b48589818885caaa8b908ba48a9687ca838b92">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2017-0091 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly available information related to this action by any of the 
following methods:
    <bullet> Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2017-0091.
    <bullet> NRC Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to <a href="/cdn-cgi/l/email-protection#abfbeff98597ca8bc3d9cecd96" mailto:Resource@nrc.gov"><span class="__cf_email__" data-cfemail="b6e4d3c5d9c3c4d5d3f6d8c4d598d1d9c0">[email protected]</span></a>">PDR.<a href="/cdn-cgi/l/email-protection#feac9b8d918b8c9d9bbe908c9dd0999188"><span class="__cf_email__" data-cfemail="683a0d1b071d1a0b0d28061a0b460f071e">[email protected]</span></a></a>. For the convenience of the reader, 
instructions about obtaining materials referenced in this document are 
provided in the ``Availability of Documents'' section.
    <bullet> NRC PDR: You may examine and purchase copies of public 
documents, by appointment, at the NRC's PDR, Room P1 B35, One White 
Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make 
an appointment to visit the PDR, please send an email to <a href="/cdn-cgi/l/email-protection#79293d2b57451859110b1c1f44" mailto:Resource@nrc.gov"><span class="__cf_email__" data-cfemail="297b4c5a465c5b4a4c69475b4a074e465f">[email protected]</span></a>">PDR.<a href="/cdn-cgi/l/email-protection#590b3c2a362c2b3a3c19372b3a773e362f"><span class="__cf_email__" data-cfemail="194b7c6a766c6b7a7c59776b7a377e766f">[email protected]</span></a></a> or call 1-800-397-4209 or 301-415-4737, between 8:00 
a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal 
holidays.

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal rulemaking website (https://www.regulations.gov). Please 
include Docket ID NRC-2017-0091 in your comment submission.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions are 
posted at https://www.regulations.gov as well as enter the comment 
submission into ADAMS. The NRC does not routinely edit comment 
submissions to remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information they do not want to be 
disclosed in the comment submission. Your request should state that the 
NRC does not routinely edit comment submissions to remove such 
information before making the comment submissions available to the 
public or entering the comment in ADAMS.

II. Discussion

    Appendix K, ``Monetary Valuation of Nonfatal Cancer Risk for Use in 
Cost-Benefit Analysis,'' to NUREG/BR-0058 provides guidance for valuing 
morbidity risks from radiation exposure for use in cost-benefit 
analyses at the NRC. This appendix includes (1) evidence-based 
estimates for the value of nonfatal cancers, (2) an overview of the 
technical approach, assumptions, and data sources used to develop these 
estimates, (3) a discussion of the uncertainties, and (4) guidance on 
how to apply these estimates in cost-benefit analyses to capture 
averted health risks from changes in radiation exposure. This valuation 
method is analogous to the

[[Page 40281]]

dollar per person-rem conversion factor for fatality risks detailed in 
NUREG-1530, Revision 1, ``Reassessment of NRC's Dollar Per Person-Rem 
Conversion Factor Policy,'' issued February 2022. The evaluation of 
morbidity impacts of nonfatal cancers will provide a more complete and 
realistic treatment of potential health effects due to radiation 
exposure in NRC cost-benefit analyses.
    Appendix L, ``Replacement Energy Costs,'' provides guidance on how 
to apply information in NUREG-2242, ``Replacement Energy Cost Estimates 
for Nuclear Power Plants: 2020-2030,'' issued June 2021, to estimate 
replacement energy costs associated with regulatory actions that may 
result in the temporary or permanent loss of electrical power 
generation from a nuclear reactor. The term ``replacement energy cost'' 
refers to the change in wholesale power prices that could result when a 
reactor unit is taken offline. This appendix presents methods and 
examples showing how to use the information in NUREG-2242 to (1) 
quantify replacement energy costs in cost-benefit analyses, including 
the calculation of shutdown costs related to installing or implementing 
mandated safety changes, and (2) estimate present value of averted 
onsite costs due to changes in reactor accident frequencies.
    The NRC staff plans to hold a public information meeting with a 
question and answer session to discuss these draft appendices to NUREG/
BR-0058, Revision 5. The public meeting will be noticed on the NRC's 
public meeting website at least 10 calendar days before the meeting. 
Members of the public should monitor the NRC's public meeting website 
at https://www.nrc.gov/pmns/mtg for additional information.

III. Availability of Documents

    The documents identified in the following table are available to 
interested persons as indicated.

------------------------------------------------------------------------
                  Document                       ADAMS accession No.
------------------------------------------------------------------------
Draft NUREG/BR[dash]0058, Revision 5,        ML22175A202.
 Appendix K, ``Monetary Valuation of
 Nonfatal Cancer Risk for Use in Cost-
 Benefit Analysis''.
Draft NUREG/BR[dash]0058, Revision 5,        ML22175A203.
 Appendix L, ``Replacement Energy Costs''.
SECY[dash]20[dash]0008, ``NUREG/             ML19261A277 (Package).
 BR[dash]0058, Revision 5, `Regulatory
 Analysis Guidelines of the U.S. Nuclear
 Regulatory Commission' ''.
SECY[dash]22[dash]0028, ``Appendices to      ML21228A118 (Package).
 NUREG/BR[dash]0058, Revision 5,
 `Regulatory Analysis Guidelines of the
 U.S. Nuclear Regulatory Commission' ''.
NUREG[dash]2242, ``Replacement Energy Cost   ML21174A176.
 Estimates for Nuclear Power Plants: 2020-
 2030''.
NUREG[dash]1530, Revision 1, ``Reassessment  ML22053A025.
 of NRC's Dollar Per Person-Rem Conversion
 Factor Policy''.
------------------------------------------------------------------------


    Dated: June 29, 2022.

    For the Nuclear Regulatory Commission.
John R. Tappert,
Director, Division of Rulemaking, Environmental, and Financial Support, 
Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2022-14287 Filed 7-5-22; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>